Gilead Sciences' new shot is a drug named lenacapavir, which was tested in two studies and reportedly eliminated HIV infections in high-risk patients. People have to test negative for HIV before they ...
Godfrey Dzhivhuho has dedicated his career to understanding HIV and other infectious diseases, inspired by the epidemic he witnessed growing up. Raised in Warrenton-Kimberly, South Africa, the oldest ...
You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...
What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best ...
The Parkland Center for Clinical Innovation (PCCI) is using AI to tackle a persistent problem: HIV infections. PCCI's Vice President of Clinical and Social Health explains how it works. Editor’s Note: ...
Harerimana Ismail of Uganda is a community health worker who checks on kids with HIV. He lost his salary after the Trump ...
The Food and Drug Administration approved a twice-yearly shot that prevented HIV infections in 99.9% of the people who received it in large clinical trials. The drug, developed by Gilead Sciences and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results